Your browser is no longer supported. Please, upgrade your browser.
Settings
ANGO AngioDynamics Inc. daily Stock Chart
ANGO [NASD]
AngioDynamics Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own1.00% Shs Outstand36.29M Perf Week0.49%
Market Cap374.51M Forward P/E14.41 EPS next Y0.72 Insider Trans0.00% Shs Float35.03M Perf Month-3.73%
Income-6.20M PEG- EPS next Q0.13 Inst Own93.70% Short Float1.63% Perf Quarter-12.98%
Sales350.40M P/S1.07 EPS this Y-212.50% Inst Trans-2.03% Short Ratio4.04 Perf Half Y-30.60%
Book/sh15.15 P/B0.68 EPS next Y20.13% ROA-0.80% Target Price14.90 Perf Year-44.52%
Cash/sh0.57 P/C18.18 EPS next 5Y15.00% ROE-1.20% 52W Range9.71 - 19.33 Perf YTD-14.99%
Dividend- P/FCF12.24 EPS past 5Y-16.90% ROI0.50% 52W High-46.61% Beta0.94
Dividend %- Quick Ratio1.30 Sales past 5Y10.60% Gross Margin49.20% 52W Low6.28% ATR0.51
Employees1300 Current Ratio2.50 Sales Q/Q-3.10% Oper. Margin-1.80% RSI (14)40.28 Volatility4.64% 4.76%
OptionableYes Debt/Eq0.24 EPS Q/Q-125.00% Profit Margin-1.80% Rel Volume0.41 Prev Close10.09
ShortableYes LT Debt/Eq0.22 EarningsJan 07 AMC Payout- Avg Volume141.57K Price10.32
Recom2.20 SMA20-4.89% SMA50-10.89% SMA200-25.80% Volume58,686 Change2.28%
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Jan-07-09Downgrade Caris & Company Buy → Above Average $20 → $15
Nov-13-08Initiated Stifel Nicolaus Hold
Sep-26-08Initiated Caris & Company Buy $20
Apr-11-08Reiterated Friedman Billings Mkt Perform $14 → $16
Apr-03-08Reiterated Friedman Billings Mkt Perform $16 → $14
Mar-07-08Downgrade Canaccord Adams Buy → Hold $25 → $16
Sep-13-07Reiterated Canaccord Adams Buy $23 → $25
Feb-10-16 02:30PM  Gov. Cuomo seeks to reframe $15 billion cost of minimum wage as 'reinvestment' at bizjournals.com
Feb-09-16 04:20PM  AngioDynamics: Health Canada Okays Celerity with Navigation
Feb-08-16 06:30AM  AngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada GlobeNewswire
Jan-20-16 11:10AM  AngioDynamics, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Jan-14-16 01:04PM  ANGIODYNAMICS INC Financials
Jan-13-16 10:28AM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-11-16 12:00PM  Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director PR Newswire
Jan-08-16 04:31PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report -5.97%
09:35AM  Stocks to Watch: Ford, Bristol-Myers, American Eagle, Alcoa at The Wall Street Journal
09:20AM  AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Jan-07-16 10:32PM  Edited Transcript of ANGO earnings conference call or presentation 7-Jan-16 9:30pm GMT
04:19PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:13PM  AngioDynamics reports 2Q loss
04:01PM  AngioDynamics Reports Fiscal 2016 Second Quarter Results GlobeNewswire
07:07AM  Q2 2016 AngioDynamics Inc Earnings Release - After Market Close
Jan-04-16 06:30AM  AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference GlobeNewswire
Jan-01-16 08:05AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : January 1, 2016
Dec-28-15 06:30AM  AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results GlobeNewswire
Dec-23-15 08:00AM  Pre-market Insights on Healthcare Sector -- Fluidigm, AngioDynamics, Tandem Diabetes Care, and BioTelemetry Accesswire
Dec-17-15 07:55AM  A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and Catalyst Pharmaceuticals Accesswire
Dec-07-15 01:00PM  AngioDynamics: FDA Calls Off Warnings Against Facilities
Dec-03-15 09:44AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : December 3, 2015
07:38AM  Early Global News: American Express Expanding In Russia, Baidu To Merge Its Music Business, China Taking Big Steps To Open Market
06:30AM  FDA Lifts Warning Letters on AngioDynamics Facilities GlobeNewswire
Nov-28-15 11:15AM  Is K12 Inc. (LRN) A Good Stock To Buy? at Insider Monkey
Nov-23-15 06:30AM  AngioDynamics to Present at the Piper Jaffray 27th Annual Healthcare Conference GlobeNewswire
Nov-18-15 04:00PM  AngioDynamics Addresses FDA Warning for NanoKnife System
Nov-17-15 06:30AM  AngioDynamics Announces Resolution of FDA Warning Letter GlobeNewswire
Nov-12-15 08:30AM  How it All Plays Out - Research on SunOpta, Arena Pharmaceuticals, AngioDynamics and Del Taco Restaurants Accesswire
Nov-11-15 06:30AM  AngioDynamics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
Nov-09-15 05:30PM  Bragar Eagel & Squire, P.C. Is Investigating the Officers and Directors of AngioDynamics, Inc. (ANGO) on Behalf of Stockholders Business Wire
04:27PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers
08:30AM  AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO GlobeNewswire
08:30AM  Analogic Announces Appointment of Mark Frost as New Chief Financial Officer GlobeNewswire
08:20AM  An Update on Stocks under Momentum - Research on A10 Networks, AngioDynamics, TRAVELCENTERS OF AMERICA and Intersect ENT Accesswire
Nov-06-15 03:42PM  ALERT: Lundin Law PC Announces Investigation of AngioDynamics Inc. And Strongly Advises Shareholders With Losses In Excess of $50,000 To Contact The Firm Business Wire
11:43AM  Glancy Prongay & Murray Commences Investigation on Behalf of AngioDynamics Inc. Investors Business Wire
Nov-03-15 08:30AM  Direction of Market Influences - Research on Cerus, Arena Pharmaceuticals, Walter Investment Management and AngioDynamics Accesswire
Nov-02-15 04:48PM  ANGIODYNAMICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Oct-28-15 06:18PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against AngioDynamics, Inc. and Encourages Investors to Contact the Firm Business Wire
12:35PM  The Wagner Firm Announces Investigation of AngioDynamics, Inc. Business Wire
Oct-21-15 04:45PM  ANGIODYNAMICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
Oct-20-15 12:40PM  AngioDynamics Expands in Asia with NanoKnife Approvals
Oct-15-15 04:25PM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  AngioDynamics Announces the Approval of the NanoKnife System in South Korea GlobeNewswire
Oct-12-15 11:03AM  AngioDynamics, Inc. Earnings Q1, 2016
Oct-09-15 09:20AM  AngioDynamics Down on In-Line Q1 Earnings, Sales Miss -6.71%
12:50AM  Edited Transcript of ANGO earnings conference call or presentation 8-Oct-15 8:30pm GMT
Oct-08-15 08:23PM  Thursday's After-Hours Movers Led By Alcoa, Ruby Tuesday, AngioDynamics And Hellen Of Troy Benzinga
05:01PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:39PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report
04:30PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  AngioDynamics reports 1Q loss
04:01PM  AngioDynamics Reports Fiscal 2016 First Quarter Results GlobeNewswire
07:07AM  Q1 2016 AngioDynamics Inc Earnings Release - After Market Close
Oct-05-15 09:10AM  Can AngioDynamics' (ANGO) Q1 Earnings Pull a Surprise?
Oct-01-15 06:30AM  AngioDynamics to Report Fiscal 2016 First Quarter Financial Results GlobeNewswire
Sep-08-15 01:45PM  AngioDynamics CEO on why new incentives in health care could benefit his company at bizjournals.com
Sep-02-15 06:30AM  AngioDynamics to Present at the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-13-15 06:30AM  Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls GlobeNewswire
Aug-12-15 08:12PM  10-K for AngioDynamics, Inc. at Company Spotlight
Aug-11-15 06:28PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against AngioDynamics, Inc. on Behalf of Investors Business Wire
Aug-10-15 06:03PM  ANGIODYNAMICS INC Files SEC form 10-K, Annual Report
04:42PM  GPM Announces Expanded Investigation of AngioDynamics, Inc. Business Wire
09:49AM  Boston Scientific Corp. Earnings Q2*, 2015
Aug-06-15 06:30AM  AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database GlobeNewswire
Aug-05-15 05:11PM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-04-15 06:31AM  AngioDynamics to Present at the Canaccord 35th Annual Growth Conference GlobeNewswire
06:31AM  AngioDynamics to Present at the 35th Annual Growth Conference GlobeNewswire
06:30AM  AngioDynamics Begins Shipment of New Midline Catheters GlobeNewswire
Jul-24-15 06:58AM  Coverage initiated on AngioDynamics by KeyBanc Capital Mkts
Jul-17-15 01:50PM  AngioDynamics Q4 Earnings Meet, Sales Hit by Forex Woes - Analyst Blog
09:22AM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Jul-16-15 07:13PM  Edited Transcript of ANGO earnings conference call or presentation 16-Jul-15 8:30pm GMT
04:31PM  AngioDynamics reports 4Q loss
04:30PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results GlobeNewswire
07:07AM  Q4 2015 AngioDynamics Inc Earnings Release - After Market Close
Jul-13-15 05:30PM  Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of AngioDynamics, Inc. Stockholders Business Wire
11:00AM  Will AngioDynamics (ANGO) Miss Q4 Earnings Estimates? - Analyst Blog
Jul-02-15 06:30AM  AngioDynamics to Report Fiscal 2015 Fourth Quarter and Full Year Financial Results GlobeNewswire
Jun-26-15 06:26AM  Edited Transcript of ANGO presentation 1-Jun-15 5:30pm GMT
May-26-15 06:30AM  AngioDynamics to Present at the Jefferies 2015 Healthcare Conference GlobeNewswire
May-20-15 12:10PM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Civil Securities Claims Against AngioDynamics, Inc. -- ANGO Business Wire
May-11-15 04:01PM  AngioDynamics to Present at the UBS Global Healthcare Conference GlobeNewswire
May-05-15 07:30AM  AngioDynamics to Present at the Bank of America Merrill Lynch Health Care Conference at noodls
06:30AM  AngioDynamics to Present at the Bank of America Merrill Lynch Health Care Conference GlobeNewswire
Apr-30-15 11:30AM  ANGO INVESTOR ALERT: AngioDynamics, Inc. Shareholders Encouraged to Contact The Wagner Firm Regarding Investigation Business Wire
Apr-28-15 10:01AM  AngioDynamics, Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing PR Newswire
Apr-23-15 08:10PM  10-Q for AngioDynamics, Inc. at Company Spotlight
Apr-14-15 08:59AM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Apr-13-15 10:30AM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Investigates Claims on Behalf of Investors of AngioDynamics, Inc. Business Wire
10:10AM  Company News for April 13, 2015 - Corporate Summary
Apr-10-15 04:09PM  Stocks gain for a second week in a row; GE soars on deal -9.42%
02:30PM  SHAREHOLDER ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of AngioDynamics, Inc. Business Wire
12:27PM  US indexes higher in midday trading; GE soars on deal news
10:50AM  AngioDynamics Lags Earnings on Lower Sales, View Tepid - Analyst Blog
06:01AM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Apr-09-15 06:05PM  AngioDynamics skids after 3Q report and reduced outlook
05:10PM  Gap shares decline as sales fall at namesake store at MarketWatch
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products for endovascular laser procedures to treat superficial venous diseases; and Sotradecol, a sclerosing drug for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides radiofrequency ablation products that use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors; microwave ablation products; and NanoKnife ablation systems for the surgical ablation of soft tissue The company sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meteny Dennis SDirectorAug 05Option Exercise15.276,00091,62059,525Aug 07 04:39 PM
JOHNSON WESLEYDirectorAug 05Option Exercise15.276,00091,62037,574Aug 06 02:05 PM
GOLD JEFFREYDirectorAug 05Option Exercise15.276,00091,62050,411Aug 06 01:58 PM
LaPorte SteveDirectorAug 05Option Exercise15.276,00091,62032,938Aug 06 01:54 PM
Greiner Charles RVP - Global FranchiseAug 05Option Exercise15.2714,100215,30738,676Aug 05 09:48 PM
Trowbridge Stephen ASVP and General CounselAug 05Option Exercise15.275,80088,56649,128Aug 05 09:47 PM
DONNELLY HOWARD WDirectorJul 16Option Exercise15.276,00091,62029,659Jul 17 07:02 PM
JOHNSON WESLEYDirectorJun 08Option Exercise16.554,64976,94126,308Jun 10 05:47 PM